Ageing Clinical and Experimental Research Group (ACER), Rm 1:128, Polwarth Building, University of Aberdeen, Aberdeen AB25 2ZN, UK.
Medicina (Kaunas). 2019 Aug 15;55(8):491. doi: 10.3390/medicina55080491.
The Scottish Intercollegiate Guidelines Network (SIGN) guideline on delirium is a major advance on existing guidelines on this condition. This is particularly important given the evidence it is frequently under-diagnosed and inadequately managed despite being common and frequently associated with significant patient and carer distress and poor outcomes. The guidelines recommend using the 4A's test to help detect delirium. A bundle of mostly non-pharmacological therapies minimise the risk of developing delirium and can help those who develop the condition. The importance of medical optimisation by an experienced professional in those at risk of delirium is highlighted with new recommendations for people in intensive care and surgical settings. There is guidance on follow-up of people with delirium, which should become routine. This commentary piece focusses on areas with the greatest potential to improve the experience and outcomes of those with delirium, and briefly discusses areas of ongoing uncertainty.
苏格兰校际指南网(SIGN)关于谵妄的指南是对现有该病症指南的重大改进。鉴于谵妄经常被漏诊且处理不当,尽管它很常见且经常与患者和照料者的严重痛苦以及较差的预后有关,这一点尤其重要。该指南建议使用 4A's 测试来帮助检测谵妄。一整套主要的非药物疗法可降低发生谵妄的风险,并有助于那些患有该病的人。通过有经验的专业人员进行医疗优化的重要性在针对重症监护和外科环境中风险人群的新建议中得到了强调。有关于谵妄患者随访的指南,应成为常规。本评论文章重点关注那些最有潜力改善谵妄患者体验和结局的领域,并简要讨论了一些持续存在的不确定性领域。